APLS Apellis Pharmaceuticals, Inc.

Fundamentals / CIK 0001492422 / USD

Apellis Pharmaceuticals, Inc. reported $1.11B in revenue and net income of $133.3M for the trailing twelve months ended March 31, 2026 (up 60.9% year over year), with a 14.9% operating margin.

Audited annual (10-K / 20-F) and quarterly (10-Q) statements parsed directly from SEC EDGAR CompanyFacts. Open APLS in the Convexity terminal for live prices, valuation multiples, transcripts, and insider flow.

Annual revenue and net income

10 fiscal years (2016 to 2025), reported in USD.

$1.07B$534.1M$0-$783.2MFY 2016 Net Income: -$27.12M2016FY 2017 Net Income: -$51.01M2017FY 2018 Net Income: -$127.5M2018FY 2019 Net Income: -$304.7M2019FY 2020 Revenue: $250.6MFY 2020 Net Income: -$344.9M2020FY 2021 Revenue: $66.56MFY 2021 Net Income: -$746.4M2021FY 2022 Revenue: $75.42MFY 2022 Net Income: -$652.2M2022FY 2023 Revenue: $396.6MFY 2023 Net Income: -$528.6M2023FY 2024 Revenue: $781.4MFY 2024 Net Income: -$197.9M2024FY 2025 Revenue: $1.00BFY 2025 Net Income: $22.39M2025

Financial statements and ratios

Reported in USD. Per-share figures and share counts are adjusted for stock splits from SEC filings.

Income Statement (Annual) · Reported in USD · Newest filing period first.

Income Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Revenue $1.00B $781.4M $396.6M $75.42M $66.56M $250.6M -- -- -- --
Research & Development $295.9M $327.6M $354.4M $387.2M $345.9M $299.9M $221.0M $105.3M $40.30M $22.98M
Selling, General & Admin $550.3M $501.1M $500.8M $277.2M -- -- -- -- -- --
Total Operating Expenses $948.4M $946.3M $913.7M $670.0M $602.8M $464.4M $288.0M $127.9M -- --
Operating Income $55.43M -$165.0M -$517.1M -$594.6M -$536.3M -$213.7M -$288.0M -$127.9M -$50.77M -$27.28M
EBITDA $56.98M -$163.2M -$515.3M -$593.1M -$534.9M -$213.1M -$287.8M -- -- --
Interest Expense $44.33M $40.39M $29.58M $32.63M $12.05M $3.58M -- -- -- --
Income Before Tax $24.11M -$196.7M -$526.5M -$651.5M -$746.0M -$343.0M -$304.7M -$127.5M -$51.01M --
Income Tax Expense $1.72M $1.16M $2.13M $669K $352K $1.84M -- -- -- --
Net Income $22.39M -$197.9M -$528.6M -$652.2M -$746.4M -$344.9M -$304.7M -$127.5M -$51.01M -$27.12M
Basic EPS $0.18 -$1.60 -$4.45 -$6.15 -$8.84 -$4.59 -$4.90 -$2.34 -$3.68 -$3.22
Diluted EPS $0.20 -$1.60 -$4.45 -$6.15 -$8.84 -$4.59 -$4.90 -$2.34 -$3.68 -$3.22
Basic Shares Outstanding 126.1M 123.9M 118.7M 106.1M 84.4M 75.2M 62.2M 54.4M 13.9M 8.4M
Diluted Shares Outstanding 129.9M 123.9M 118.7M 106.1M 84.4M 75.2M 62.2M 54.4M 13.9M 8.4M

Income Statement (Quarterly) · Reported in USD · Newest filing period first.

Income Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Revenue $268.3M $199.9M $458.6M $178.5M $166.8M $212.5M $196.8M $199.7M
Research & Development $76.96M $74.23M $68.19M $67.02M $86.42M $76.35M $88.57M $77.95M
Selling, General & Admin $124.3M $147.1M $142.7M $131.1M $129.3M $121.5M $122.0M $128.1M
Total Operating Expenses $241.8M $251.1M $235.4M $211.8M $250.1M $238.7M $244.1M $229.1M
Operating Income $26.47M -$51.14M $223.2M -$33.29M -$83.33M -$26.16M -$47.28M -$29.44M
EBITDA $26.76M -$50.81M $223.5M -$32.84M -$82.88M -$25.72M -$46.82M -$28.99M
Interest Expense $10.32M $10.85M $11.28M $11.15M $11.05M $11.53M $12.53M $9.36M
Income Before Tax $19.15M -$58.64M $216.3M -$41.69M -$91.88M -$36.07M -$56.85M -$37.54M
Income Tax Expense $496K $313K $602K $466K $341K $286K $592K $114K
Net Income $18.66M -$58.95M $215.7M -$42.15M -$92.22M -$36.35M -$57.45M -$37.66M
Basic EPS $0.15 -- $1.71 -$0.33 -$0.74 -- -$0.46 -$0.30
Diluted EPS $0.15 -- $1.67 -$0.33 -$0.74 -- -$0.46 -$0.30
Basic Shares Outstanding 127.7M -- 126.4M 126.0M 125.5M -- 124.2M 123.9M
Diluted Shares Outstanding 131.4M -- 130.1M 126.0M 125.5M -- 124.2M 123.9M

Balance Sheet (Annual) · Reported in USD · Newest filing period first.

Balance Sheet Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Cash & Cash Equivalents $466.2M $411.3M $351.2M $551.8M $640.2M $565.8M $352.0M $176.3M $175.6M $24.86M
Short-Term Investments -- -- -- -- $60.36M $311.9M -- -- -- --
Cash & Short-Term Investments $466.2M $411.3M $351.2M $551.8M $700.5M $877.6M $352.0M $176.3M $175.6M $24.86M
Accounts Receivable, Net $366.2M $264.9M $206.4M $7.73M $10.10M -- -- -- -- --
Inventory $142.6M $81.40M $146.4M $85.71M $16.29M $0 -- -- -- --
Other Current Assets -- $11.64M $22.41M $36.66M $70.68M $26.88M $1.31M $1.84M $15K $25K
Total Current Assets $1.01B $789.0M $766.3M $719.5M $824.0M $917.2M $373.1M $202.4M $182.0M $27.37M
Property, Plant & Equipment, Net $1.71M $2.95M $4.34M $6.15M $6.18M $6.80M $1.66M $978K -- --
Other Non-Current Assets $5.55M $1.35M $1.31M $15.80M $31.64M $18.86M $385K $116K $116K $65K
Total Non-Current Assets $60.42M $96.10M $22.40M $40.69M $57.72M $43.38M $16.15M $1.09M $116K $65K
Total Assets $1.08B $885.1M $788.7M $760.2M $881.8M $960.6M $389.2M $203.5M $182.1M $27.43M
Accounts Payable $56.80M $38.57M $37.52M $37.34M $16.91M $8.48M $8.36M $10.25M $3.66M $2.55M
Short-Term Debt -- -- -- -- -- -- -- $1.67M -- --
Total Current Liabilities $323.6M $185.5M $247.6M $167.6M $131.8M $128.3M $65.75M $17.02M $6.55M $3.64M
Long-Term Debt -- -- $93.03M $92.74M -- -- -- -- $27.00M --
Other Non-Current Liabilities $7.90M $7.97M $2.31M -- -- -- -- $159K -- --
Total Non-Current Liabilities $381.5M $471.0M $346.6M $422.7M $551.3M $627.7M $289.3M $25.54M $26.63M $0
Total Liabilities $705.1M $656.5M $594.2M $590.3M $683.1M $756.0M $355.0M $42.56M $33.19M $3.64M
Total Debt (incl. Leases) $19.03M $16.95M $110.9M $112.7M $21.20M $18.90M $14.47M $1.67M $27.00M --
Common Stock $12K $12K $12K $11K $10K $8.0K $6.0K $5.6K $5.0K $843
Retained Earnings -$3.01B -$3.04B -$2.84B -$2.31B -$1.66B -$926.3M -$581.5M -$276.8M -$149.3M -$98.26M
Accumulated Other Comp. Income -$2.10M -$3.31M -$3.54M -$875K -$2.09M -$117K -$154K -$123K -- --
Total Stockholders' Equity $370.1M $228.5M $194.5M $169.9M $198.7M $204.6M $34.23M $161.0M $148.9M $23.79M
Total Equity $370.1M $228.5M $194.5M $169.9M $198.7M $204.6M $34.23M $161.0M $148.9M $23.79M

Balance Sheet (Quarterly) · Reported in USD · Newest filing period first.

Balance Sheet 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Cash & Cash Equivalents $405.2M $466.2M $479.2M $370.0M $358.4M $411.3M $396.9M $360.1M
Cash & Short-Term Investments $405.2M $466.2M $479.2M $370.0M $358.4M $411.3M $396.9M $360.1M
Accounts Receivable, Net $440.3M $366.2M $345.5M $214.1M $235.2M $264.9M $279.0M $304.4M
Inventory $131.4M $142.6M $122.8M $121.0M $82.47M $81.40M $121.1M $152.8M
Other Current Assets -- -- $10.16M $19.84M $13.07M $11.64M $11.78M $12.37M
Total Current Assets $1.03B $1.01B $990.7M $755.6M $727.7M $789.0M $833.9M $860.0M
Property, Plant & Equipment, Net $1.42M $1.71M $1.93M $2.12M $2.51M $2.95M $3.38M $3.84M
Other Non-Current Assets $5.66M $5.55M $5.49M $898K $1.15M $1.35M $1.45M $1.33M
Total Non-Current Assets $54.51M $60.42M $68.05M $65.78M $79.57M $96.10M $67.97M $44.51M
Total Assets $1.08B $1.08B $1.06B $821.4M $807.3M $885.1M $901.9M $904.5M
Accounts Payable $49.05M $56.80M $38.60M $54.24M $55.29M $38.57M $42.73M $38.27M
Total Current Liabilities $283.4M $323.6M $279.5M $200.7M $178.4M $185.5M $191.3M $169.2M
Other Non-Current Liabilities $9.11M $7.90M $3.26M $2.08M $2.08M $7.97M $9.83M $2.69M
Total Non-Current Liabilities $384.2M $381.5M $378.0M $464.4M $464.7M $471.0M $473.5M $471.0M
Total Liabilities $667.6M $705.1M $657.6M $665.1M $643.1M $656.5M $664.7M $640.2M
Total Debt (incl. Leases) $19.77M $19.03M $20.70M $15.73M $16.13M $16.95M $18.20M $17.30M
Common Stock $13K $12K $12K $12K $12K $12K $12K $12K
Retained Earnings -$2.99B -$3.01B -$2.95B -$3.17B -$3.13B -$3.04B -$3.00B -$2.94B
Accumulated Other Comp. Income -$2.41M -$2.10M -$2.40M -$2.57M -$3.05M -$3.31M -$3.14M -$3.36M
Total Stockholders' Equity $414.9M $370.1M $401.2M $156.3M $164.2M $228.5M $237.1M $264.3M
Total Equity $414.9M $370.1M $401.2M $156.3M $164.2M $228.5M $237.1M $264.3M

Cash Flow Statement (Annual) · Reported in USD · Newest filing period first.

Cash Flow Statement Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Net Income $22.39M -$197.9M -$528.6M -$652.2M -$746.4M -$344.9M -$304.7M -$127.5M -$51.01M -$27.12M
Depreciation & Amortization $1.56M $1.80M $1.78M $1.55M $1.38M $637K $240K -- -- --
Stock-Based Compensation $104.0M $114.1M $105.9M $91.08M $70.67M $45.38M $21.14M $7.73M $5.42M $1.08M
Change in Receivables -$101.3M -$58.48M -$198.7M $2.38M -$10.10M -- -- -- -- --
Change in Inventory -$15.27M -$10.76M -$60.65M -$69.40M -$16.32M -- -- -- -- --
Change in Payables $18.22M $1.09M $170K $18.69M $10.49M -$54K -$1.64M -$978K -$52K $70K
Operating Cash Flow $45.33M -$87.87M -$594.7M -$513.7M -$563.1M -$160.5M -$211.1M -$131.2M -$46.60M -$26.00M
Capital Expenditure -$313K -$403K -$773K -$1.52M -$1.10M -$5.42M -$1.69M -- -- --
Free Cash Flow $45.01M -$88.27M -$595.5M -$515.3M -$564.2M -$165.9M -$212.8M -- -- --
Purchases of Investments -- -- -- -$331.9M -$171.3M -$879.1M -- -- -- --
Investing Cash Flow -$313K -$403K -$674K $59.89M $247.6M -$317.0M -$1.69M -- -- --
Common Stock Issued -- -- -- $380.1M $380.4M $381.4M $109.6M $131.2M $150.1M --
Financing Cash Flow $8.88M $149.2M $394.5M $365.7M $392.2M $692.2M $388.5M $131.9M $197.4M $14.86M
Net Change in Cash $55.15M $60.31M -$200.8M -$88.68M $74.71M $215.1M $175.7M $624K $150.8M -$11.14M

Cash Flow Statement (Quarterly) · Reported in USD · Newest filing period first.

Cash Flow Statement 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Net Income $18.66M -$58.95M $215.7M -$42.15M -$92.22M -$36.35M -$57.45M -$37.66M
Depreciation & Amortization $291K $327K $339K $446K $446K $447K $457K $449K
Stock-Based Compensation $25.17M $21.25M $28.19M $27.20M $27.37M $26.31M $27.48M $29.99M
Change in Receivables -$74.07M -$20.67M -$131.4M $21.12M $29.68M $14.09M $25.42M -$36.58M
Change in Inventory $18.81M -$8.66M $5.40M -$26.01M $14.00M $10.02M $8.65M -$14.51M
Change in Payables -$7.74M $18.20M -$15.64M -$1.04M $16.71M $1.49M -$1.16M $11.49M
Operating Cash Flow -$60.97M -$14.18M $108.5M $4.45M -$53.41M $19.36M $34.10M -$8.34M
Capital Expenditure -- -$108K -$148K -$49K -$8.0K -$20K $0 -$90K
Free Cash Flow -- -$14.28M $108.3M $4.40M -$53.42M $19.34M $34.10M -$8.43M
Investing Cash Flow -- -$108K -$148K -$49K -$8.0K -$20K $0 -$90K
Financing Cash Flow $64K $1.26M $793K $6.56M $274K -$4.00M $2.54M $42.49M
Net Change in Cash -$61.03M -$12.84M $109.1M $11.64M -$52.78M $14.38M $36.81M $34.40M

Margins, returns, leverage, liquidity, and year-over-year growth computed directly from SEC EDGAR statement levels. Multi-year figures show cumulative per-share growth.

Ratios & Growth Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31 Dec 31
Operating Margin 5.5% -21.1% -130.4% -788.4% -805.7% -85.3% -- -- -- --
Net Profit Margin 2.2% -25.3% -133.3% -864.7% -1121.3% -137.6% -- -- -- --
Return on Equity (ROE) 6.0% -86.6% -271.8% -383.9% -375.7% -168.6% -890.2% -79.2% -34.2% -114.0%
Return on Assets (ROA) 2.1% -22.4% -67.0% -85.8% -84.6% -35.9% -78.3% -62.6% -28.0% -98.9%
Current Ratio 3.14x 4.25x 3.10x 4.29x 6.25x 7.15x 5.67x 11.89x 27.77x 7.52x
Quick Ratio 2.70x 3.81x 2.50x 3.78x 6.13x 7.15x 5.35x 10.35x 26.80x 6.83x
Debt to Equity 0.05x 0.07x 0.57x 0.66x 0.11x 0.09x 0.42x 0.01x 0.18x --
Revenue Growth (YoY) +28.5% +97.0% +425.8% +13.3% -73.4% -- -- -- -- --
5Y Revenue / Share Growth +138.6% -- -- -- -- -- -- -- -- --

Quarterly margins, ROE, and ROA use trailing-twelve-month (TTM) flows summed across four contiguous quarters. Growth rates are true year-over-year comparisons against the same quarter a year earlier.

Ratios & Growth 2026-03-31 2025-12-31 2025-09-30 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Operating Margin 14.9% 5.5% 7.9% -25.2% -24.0% -21.1% -31.2% -49.8%
Net Profit Margin 12.1% 2.2% 4.4% -30.2% -28.8% -25.3% -35.0% -52.9%
Return on Equity (ROE) 32.1% 6.0% 11.2% -146.0% -136.2% -86.6% -105.5% -125.9%
Return on Assets (ROA) 12.3% 2.1% 4.2% -27.8% -27.7% -22.4% -27.7% -36.8%
Current Ratio 3.63x 3.14x 3.54x 3.77x 4.08x 4.25x 4.36x 5.08x
Quick Ratio 3.16x 2.70x 3.10x 3.16x 3.62x 3.81x 3.73x 4.18x
Debt to Equity 0.05x 0.05x 0.05x 0.10x 0.10x 0.07x 0.08x 0.07x
Revenue Growth (YoY) +60.9% -5.9% +133.0% -10.6% -3.2% +45.2% +78.3% +110.3%
Operating Cash Flow Growth (YoY) -- -173.2% +218.1% -- -- -- -- --
Free Cash Flow Growth (YoY) -- -173.9% +217.7% -- -- -- -- --
Source: SEC EDGAR CompanyFacts (CIK 0001492422) · from December 31, 2015 Data through March 31, 2026 · synced Nov 20, 2026, 05:15 UTC · Open in terminal